SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease

NCT05332678 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Alzheimer's Disease

Interventions

DRUG: SLS-005 - Once Weekly
DRUG: SLS-005 - Twice Weekly

Sponsor

Seelos Therapeutics, Inc.